 |
市場調查報告書
商品編碼
1673009
叢集性頭痛市場：按類型、藥物類型、給藥途徑、分銷管道和地區分類Cluster Headache Market, By Type, By Drug Type, By Route of Administration, By Distribution Channel, By Geography |
||||||
價格
簡介目錄
2025 年全球叢集性頭痛市場規模估計為 4.493 億美元，預計到 2032 年將達到 6.94 億美元，2025 年至 2032 年的年複合成長率（CAGR）為 6.4%。
| 報告範圍 | 報告詳細資訊 | ||
|---|---|---|---|
| 基準年 | 2024 | 2025 年市場規模 | 4.493億美元 |
| 效能資料 | 2020-2024 | 預測期 | 2025-2032 |
| 預測期：2025 年至 2032 年複合年成長率 | 6.40% | 2032 年金額預測 | 6.94億美元 |
數字。 2025 年叢集性頭痛市場佔有率（按地區分類）
叢集性頭痛是一種神經系統疾病，其特徵是連續發作的嚴重頭痛，每次持續 15 至 180 分鐘。它常常影響頭部的一側，導致眼睛和太陽穴周圍劇烈疼痛。確切原因尚不清楚，但可能的誘因包括飲酒、失眠、過敏和睡眠模式改變。據估計，全世界約有 0.1% 的人口（約 300 萬人）受到影響。男女比例為3：1，男性患病人數多於女性。它通常發生在20至50歲之間。雖然不會危及生命，但劇烈的疼痛會嚴重影響生活品質。治療方案包括急性治療，例如氧氣療法和曲坦類藥物以緩解症狀，以及預防性治療，例如維拉帕米以減少發作的頻率和強度。預計在不久的將來，對症狀管理的認知的提高和醫療保健支出的增加將推動全球叢集性頭痛市場的成長。
市場動態
全球叢集性頭痛市場的成長得益於診斷率的上升以及人們對該病症及其治療的認知的提高。根據2020年全球流行病學研究，由於患者和醫師缺乏認知，叢集性頭痛常被誤診。但非營利組織日益增多的醫學教育舉措正在幫助提高診斷率。預計這將推動對急性和預防治療方案的需求。此外，新興國家醫療保健支出的增加也將推動市場的發展。然而，高昂的治療成本（尤其是在新興經濟體）可能會阻礙市場成長。核准學名藥的短缺導致治療成本增加。在預測期內，持續研究和開發有效且經濟實惠的治療方案可以為市場參與企業提供新的機會。
研究的主要特點
- 本報告對全球叢集性頭痛市場進行了詳細分析，並以 2024 年為基準年，給出了預測期（2025-2032 年）的市場規模和年複合成長率（CAGR%）。
- 它還強調了各個領域的潛在商機並說明了該市場的有吸引力的投資提案矩陣。
- 它還提供了關於市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景以及主要企業採用的競爭策略的主要考察。
- 它根據公司亮點、產品系列、關鍵亮點、業績和策略等參數列出了全球叢集性頭痛市場的主要企業簡介。
- 本報告的見解將使負責人和企業經營團隊能夠就未來產品發布、新興趨勢、市場擴張和行銷策略做出明智的決策。
- 全球叢集性頭痛市場報告迎合了該行業的各個相關人員，例如投資者、供應商、產品製造商、經銷商、新進業者和金融分析師。
- 相關人員將透過全球叢集性頭痛市場分析中使用的各種策略矩陣更輕鬆地做出決策。
目錄
第1章 調查目的與前提條件
- 研究目標
- 先決條件
- 簡稱
第2章 市場展望
- 報告描述
- 市場定義和範圍
- 執行摘要
- 一致的機會圖 (COM)
第3章市場動態、法規與趨勢分析
- 市場動態
- 驅動程式
- 限制因素
- 機會
- 影響分析
- 市場趨勢
- 監管情景
- 收購和合作場景
- 資金籌措和投資
- PEST分析
- 波特的分析
4. 全球叢集性頭痛市場-冠狀病毒 (COVID-19) 大流行的影響
- 整體影響
- 政府舉措
- COVID-19 市場影響
5. 2020 年至 2032 年全球叢集性頭痛市場（按類型分類）（百萬美元）
- 介紹
- 陣發性
- 慢性的
6. 2020-2032 年全球叢集性頭痛市場（按藥物類型分類）（百萬美元）
- 介紹
- 速效藥物
- 長期服藥
- 短期用藥
7. 2020 年至 2032 年全球叢集性頭痛市場，依給藥途徑分類（百萬美元）
- 介紹
- 口服
- 局部的
- 靜脈
- 其他
8. 2020-2032 年全球叢集性頭痛市場按分銷管道分類（百萬美元）
- 介紹
- 醫院藥房
- 零售藥局
- 網路藥局
9. 2020 年至 2032 年全球叢集性頭痛市場（按地區分類）（百萬美元）
- 介紹
- 北美洲
- 拉丁美洲
- 歐洲
- 亞太地區
- 中東
- 非洲
第10章 競爭格局
- 公司簡介
- Autonomic Technologies, Inc.
- Epic Systems Corporation
- AstraZeneca
- ElectroCore, Inc.
- Eli Lilly and Company
- Hoffmann-La Roche Ltd
- Novartis AG
- Pfizer Inc.
- Sun Pharmaceutical Industries Ltd.
- Teva Pharmaceutical Industries Ltd.
- WL Gore &Associates, Inc.
- Zosano Pharma
- Allergan, plc
- Amgen Inc.
- Biohaven Pharmaceutical Holding Company Ltd.
- Cefaly Technology
- Eliem Therapeutics, Inc.
- Lundbeck Seattle BioPharmaceuticals, Inc.
- Prismic Pharmaceuticals, Inc.
- Sanofi
- Upsher-Smith Laboratories, LLC
第 11 章 分析師建議
- 興衰
- 一致的機會地圖
第 12 章參考文獻與調查方法
- 參考
- 調查方法
簡介目錄
Product Code: CMI4709
Global Cluster Headache Market is estimated to be valued at USD 449.3 Mn in 2025 and is expected to reach USD 694.0 Mn by 2032, growing at a compound annual growth rate (CAGR) of 6.4% from 2025 to 2032.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2024 | Market Size in 2025: | USD 449.3 Mn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2025 To 2032 |
| Forecast Period 2025 to 2032 CAGR: | 6.40% | 2032 Value Projection: | USD 694.0 Mn |
Figure. Cluster Headache Market Share (%), By Region 2025
Cluster headache is a neurological condition characterized by severe headaches occurring in clusters with each headache lasting 15-180 minutes. It often affects one side of the head and causes excruciating pain around the eye and temple. The exact cause remains unknown but some potential triggers include alcohol consumption, insomnia, allergies, and changes in sleeping patterns among others. It is estimated to affect around 0.1% of the general population worldwide or roughly 3 million people. Men are affected more than women with a male to female ratio of 3:1. It usually develops between the ages of 20-50. While it is not life-threatening, the intense pain severely affects quality of life. Treatment options include acute therapies like oxygen and triptans for symptom relief and preventive therapies like verapamil to reduce the frequency and intensity of attacks. Growing awareness about condition management and rising healthcare expenditure are expected to drive the global cluster headache market growth in the near future.
Market Dynamics:
Global cluster headache market growth is driven by increasing diagnosis rate and growing awareness about the condition and its management. According to a Global Epidemiology Study in 2020, cluster headache is often underdiagnosed due to lack of awareness in both patients and physicians. However, growing medical education initiatives by non-profit organizations help to improve diagnosis rate. This is expected to boost demand for acute and preventive treatment options. Furthermore, rising healthcare spending in developing countries can also drive the market growth. However, high treatment cost, especially in developing economies, can hamper the market growth. Lack of approved generic drugs increases treatment cost. Ongoing R&D for effective and affordable treatment options can provide new opportunities for market participants over the forecast period.
Key features of the study:
- This report provides in-depth analysis of the global cluster headache market, and provides market size (USD Million) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global cluster headache market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Eli Lilly and Company, Teva Pharmaceutical Industries, Sun Pharmaceutical Industries, TrioxBio Inc.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- Global cluster headache market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global cluster headache market
Detailed Segmentation-
- By Type
- Episodic
- Chronic
- By Drug Type
- Fast-acting Drugs
- Long-term Drugs
- Short-term Drugs
- By Route of Administration
- Oral
- Topical
- Intravenous
- Others
- By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
- Company Profiles:
- Autonomic Technologies, Inc.
- Epic Systems Corporation
- AstraZeneca
- ElectroCore, Inc.
- Eli Lilly and Company
- F. Hoffmann-La Roche Ltd
- Novartis AG
- Pfizer Inc.
- Sun Pharmaceutical Industries Ltd.
- Teva Pharmaceutical Industries Ltd.
- W. L. Gore & Associates, Inc.
- Zosano Pharma
- Allergan, plc
- Amgen Inc.
- Biohaven Pharmaceutical Holding Company Ltd.
- Cefaly Technology
- Eliem Therapeutics, Inc.
- Lundbeck Seattle BioPharmaceuticals, Inc.
- Prismic Pharmaceuticals, Inc.
- Sanofi
- Upsher-Smith Laboratories, LLC
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Type
- Market Snapshot, By Drug Type
- Market Snapshot, By Route of Administration
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Opportunities
- Impact Analysis
- Market Trends
- Key Developments
- Regulatory Scenario
- Acquisitions and Partnerships Scenario
- Funding and Investments
- PEST Analysis
- Porter's Analysis
4. Global Cluster Headache Market - Impact of Coronavirus (COVID-19) Pandemic
- Overall Impact
- Government Initiatives
- COVID-19 Impact on the Market
5. Global Cluster Headache Market, By Type, 2020 - 2032, (USD Mn)
- Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Episodic
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Chronic
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
6. Global Cluster Headache Market, By Drug Type, 2020 - 2032, (USD Mn)
- Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Fast-acting Drug
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Long-term Drugs
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Short-term Drugs
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
7. Global Cluster Headache Market, By Route of Administration, 2020 - 2032, (USD Mn)
- Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Oral
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Topical
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Intravenous
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
8. Global Cluster Headache Market, By Distribution Channel, 2020 - 2032, (USD Mn)
- Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Hospital Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Retail Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Online Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
9. Global Cluster Headache Market, By Region, 2020 - 2032, (USD Mn)
- Introduction
- Market Share Analysis, By Region, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, For Region, 2021-2032
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Mn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Mn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Mn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Mn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Mn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020 - 2032, (USD Mn)
- North Africa
- Central Africa
- South Africa
10. Competitive Landscape
- Company Profiles
- Autonomic Technologies, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Epic Systems Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- AstraZeneca
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- ElectroCore, Inc.
- Eli Lilly and Company
- Hoffmann-La Roche Ltd
- Novartis AG
- Pfizer Inc.
- Sun Pharmaceutical Industries Ltd.
- Teva Pharmaceutical Industries Ltd.
- W.L. Gore & Associates, Inc.
- Zosano Pharma
- Allergan, plc
- Amgen Inc.
- Biohaven Pharmaceutical Holding Company Ltd.
- Cefaly Technology
- Eliem Therapeutics, Inc.
- Lundbeck Seattle BioPharmaceuticals, Inc.
- Prismic Pharmaceuticals, Inc.
- Sanofi
- Upsher-Smith Laboratories, LLC
- Autonomic Technologies, Inc.
11. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
12. References and Research Methodology
- References
- Research Methodology
- About us and Sales Contact
